Member Info for 86KB

Wonder if lanstead are out, had around 28mill shares left on Dec 10th, we have done nearly 65million in volume. Should get holdings rns if so and then it should really get going.

ImmuPharma value will be realised because….

▪ Mid to late-stage pipeline with significant product differentiation

▪ High medical need and commercially attractive markets

▪ Biotech company peers are valued at least 100x higher on average by the

markets

▪ Biotech’s with similar stage products valued ~$680-1750m

▪ ImmuPharma ~$10m

4p shown in auction could get taken out soon. Could we see double digits going into next week? Time will tell.

K3vmc like I said anything can happen in the next few months and board also believes key milestone to be met in the period. So they could still get a decent return from them warrants.

ImmuPharma's Board believes that the Incanthera investment case is robust and that there is potential for a further accretive share price, based on key milestones being met over the next period to 31 March 2025.

Well as I said earlier 10p would only be £41mcap, around 25p to take it to £100m mcap. These use to be in the pounds.

F1 perhaps another update before or after the event next week.

Howard warrants have been extended so anything can happen with Incanthera plus they are not worthless currently worth £365k.

You have to look at other companies who are in the autoimmune disease market and see where they are at, only then you will realise how undervalued this is.

Major Players:

Pfizer Inc.

Bristol-Myers Squibb Company

F. Hoffmann-La Roche Ltd.

Novartis AG

Abbott Laboratories

AbbVie Inc.

Amgen Inc.

Johnson & Johnson

AstraZeneca Plc

UCB S.A.

Biogen Idec Inc.

Chugai Pharmaceutical Co. Ltd.

Danaher

Bayer Schering Pharma AG

Elan Corporation Plc

Eli Lilly and Company

GlaxoSmithKline Plc

HYCOR Biomedical

Merck & Co. Inc.

Bobat they still have 7.3 million warrants in Incanthera can sell them anytime for funds.

Think it rises into next week, the mcap is far to low for what they have just announced.

Wonder who has shown interest

The findings we have announced today highlight the extremely diligent and focused research we have been conducting behind the scenes at Immupharma Biotech in order to better characterise and explain our lead asset P140 and its application in autoimmune diseases, which is now gaining significant attention within the biopharmaceutical industry."

Looks could get some new partners and commercial deals coming soon.

We remain committed as a Board, on the development of P140 in SLE and CIDP, our two key late-stage clinical assets, together with securing additional partnering for P140. We have made significant scientific progress over the last period, including refinement of the protocols for the SLE and CIDP studies and new insights into the MOA of P140, and as a result, we have a high level of confidence of the success of these new studies.

We will also continue to concentrate on securing further commercial and partnering deals, on which we have made significant progress over the last 6 months.

4p would have mcap of only £16.6mil, worth much more than that imo. 7-8p is only £29-33mil mcap. 10p is £41m

Mcap below 10mcap is crazy when looking at this

According to SNS Insider, The Global Autoimmune Disease Therapeutics Market was valued at USD 72.34 Billion in 2023 and is projected to reach USD 116.81 Billion by 2032, growing at a compound annual growth rate (CAGR) of 5.52% from 2024 to 2032.”13 Dec 2024

https://www.globenewswire.com › ...

The Feasibility Study released in June 2020 indicated the Project has the potential to be among the lowest capital cost development stage potash projects in the world and also, as a result of its location, one of the highest margin projects. Updated financial estimates published in February 2024 indicated a net present value of US$2.2 billion, with an internal rate of return of approximately 40%.

Have a read through this report

https://www.dropbox.com/scl/fi/24u0yd2f2sb2mb1pcrz3d/Emmerson-ENGv.pdf?rlkey=yovzsajmcld9an7qq47sfi6yf&e=1&st=hdvxu6kj&dl=0

PJ we all know the warrants have been repriced, you do not need to repeat yourself over and over again. You forget to add that warrants have raised £416k plus another £153k on the outstanding warrants. You have no interest in this share so just do something else with your time and not waste it on here. Plus when there are no more warrants nothing to hold it down.

Old interview from December but a good reminder of whats to come.

https://x.com/ausstockchick/status/1868487905553051965?t=dGLtdo45ah-rSR7kU1xk9Q&s=19

Its a false spread

Definitely, warrants dragged it down. But now they have funds they can get things going. Could get further drill results too for Northern zone as we await for mining lease approval. As was mentioned they will continue to drill. Its a huge high gold grade porphyry so lots more news for that in between then.

*Warrants funds